Cargando…

Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro

The preparation of platelet-rich fibrin (PRF) requires blood centrifugation to separate the yellow plasma from the red erythrocyte fraction. PRF membranes prepared from coagulated yellow plasma are then transferred to the defect sites to support tissue regeneration. During natural wound healing, how...

Descripción completa

Detalles Bibliográficos
Autores principales: Kargarpour, Zahra, Panahipour, Layla, Miron, Richard J., Gruber, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180540/
https://www.ncbi.nlm.nih.gov/pubmed/35682575
http://dx.doi.org/10.3390/ijms23115897
_version_ 1784723544717918208
author Kargarpour, Zahra
Panahipour, Layla
Miron, Richard J.
Gruber, Reinhard
author_facet Kargarpour, Zahra
Panahipour, Layla
Miron, Richard J.
Gruber, Reinhard
author_sort Kargarpour, Zahra
collection PubMed
description The preparation of platelet-rich fibrin (PRF) requires blood centrifugation to separate the yellow plasma from the red erythrocyte fraction. PRF membranes prepared from coagulated yellow plasma are then transferred to the defect sites to support tissue regeneration. During natural wound healing, however, it is the unfractionated blood clot (UBC) that fills the defect site. It is unclear whether centrifugation is necessary to prepare a blood-derived matrix that supports tissue regeneration. The aim of the present study was to compare lysates prepared from PRF and UBC based on bioassays and degradation of the respective membranes. We report here that lysates prepared from PRF and UBC membranes similarly activate TGF-β signaling, as indicated by the expression of interleukin 11 (IL-11), NADPH oxidase 4 (NOX-4) and proteoglycan 4 (PRG4) in gingival fibroblasts. Consistently, PRF and UBC lysates stimulated the phosphorylation and nuclear translocation of Smad3 in gingival fibroblasts. We further observed that PRF and UBC lysates have comparable anti-inflammatory activity, as shown by the reduction in lipopolysaccharide (LPS)-induced IL-6, inducible nitric oxidase synthase (iNOS) and cyclooxygenase 2 (COX-2) expression in RAW264.7 cells. Moreover, inflammation induced by Poly (1:C) HMW and FSL-1, which are agonists of Toll-like receptor (TLR) 3 and 2/6, respectively, was reduced by both PRF and UBC. PRF and UBC lysates reduced the nuclear translocation of p65 in LPS-induced RAW264.7 cells. In contrast to the similar activity observed in the bioassays, UBC membranes lack the structural integrity of PRF membranes, as indicated by the rapid and spontaneous disintegration of UBC membranes. We show here that the lysates prepared from PRF and UBC possess robust TGF-β and anti-inflammatory activity. However, visual inspection of the PRF and UBC membranes confirmed the negative impact of erythrocytes on the structural integrity of membranes prepared from whole blood. The data from the present study suggest that although both UBC and PRF have potent TGF-β and anti-inflammatory activity, UBC does not have the strength properties required to be used clinically to prepare applicable membranes. Thus, centrifugation is necessary to generate durable and clinically applicable blood-derived membranes.
format Online
Article
Text
id pubmed-9180540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91805402022-06-10 Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro Kargarpour, Zahra Panahipour, Layla Miron, Richard J. Gruber, Reinhard Int J Mol Sci Article The preparation of platelet-rich fibrin (PRF) requires blood centrifugation to separate the yellow plasma from the red erythrocyte fraction. PRF membranes prepared from coagulated yellow plasma are then transferred to the defect sites to support tissue regeneration. During natural wound healing, however, it is the unfractionated blood clot (UBC) that fills the defect site. It is unclear whether centrifugation is necessary to prepare a blood-derived matrix that supports tissue regeneration. The aim of the present study was to compare lysates prepared from PRF and UBC based on bioassays and degradation of the respective membranes. We report here that lysates prepared from PRF and UBC membranes similarly activate TGF-β signaling, as indicated by the expression of interleukin 11 (IL-11), NADPH oxidase 4 (NOX-4) and proteoglycan 4 (PRG4) in gingival fibroblasts. Consistently, PRF and UBC lysates stimulated the phosphorylation and nuclear translocation of Smad3 in gingival fibroblasts. We further observed that PRF and UBC lysates have comparable anti-inflammatory activity, as shown by the reduction in lipopolysaccharide (LPS)-induced IL-6, inducible nitric oxidase synthase (iNOS) and cyclooxygenase 2 (COX-2) expression in RAW264.7 cells. Moreover, inflammation induced by Poly (1:C) HMW and FSL-1, which are agonists of Toll-like receptor (TLR) 3 and 2/6, respectively, was reduced by both PRF and UBC. PRF and UBC lysates reduced the nuclear translocation of p65 in LPS-induced RAW264.7 cells. In contrast to the similar activity observed in the bioassays, UBC membranes lack the structural integrity of PRF membranes, as indicated by the rapid and spontaneous disintegration of UBC membranes. We show here that the lysates prepared from PRF and UBC possess robust TGF-β and anti-inflammatory activity. However, visual inspection of the PRF and UBC membranes confirmed the negative impact of erythrocytes on the structural integrity of membranes prepared from whole blood. The data from the present study suggest that although both UBC and PRF have potent TGF-β and anti-inflammatory activity, UBC does not have the strength properties required to be used clinically to prepare applicable membranes. Thus, centrifugation is necessary to generate durable and clinically applicable blood-derived membranes. MDPI 2022-05-24 /pmc/articles/PMC9180540/ /pubmed/35682575 http://dx.doi.org/10.3390/ijms23115897 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kargarpour, Zahra
Panahipour, Layla
Miron, Richard J.
Gruber, Reinhard
Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro
title Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro
title_full Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro
title_fullStr Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro
title_full_unstemmed Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro
title_short Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro
title_sort blood clots versus prf: activating tgf-β signaling and inhibiting inflammation in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180540/
https://www.ncbi.nlm.nih.gov/pubmed/35682575
http://dx.doi.org/10.3390/ijms23115897
work_keys_str_mv AT kargarpourzahra bloodclotsversusprfactivatingtgfbsignalingandinhibitinginflammationinvitro
AT panahipourlayla bloodclotsversusprfactivatingtgfbsignalingandinhibitinginflammationinvitro
AT mironrichardj bloodclotsversusprfactivatingtgfbsignalingandinhibitinginflammationinvitro
AT gruberreinhard bloodclotsversusprfactivatingtgfbsignalingandinhibitinginflammationinvitro